The history of Viagra, and its creator copyright, presents a challenging case study for investors. Originally a blockbuster drug, producing billions in income, its patent expiration created a deluge of lower-priced alternatives , significantly eroding its position . While certain firms may seek to capitalize on male sexual dysfunction, the current